Scott Investment Partners’s Gilead Sciences GILD Stock Holding History

Scott Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$959K	Hold	12,800	–	–	2.2%	20
2023 Q2	$986K	Hold	12,800	–	–	2.22%	22
2023 Q1	$1.06M	Hold	12,800	–	–	2.45%	16
2022 Q4	$1.1M	Hold	12,800	–	–	2.65%	13
2022 Q3	$790K	Hold	12,800	–	–	2.12%	26
2022 Q2	$791K	Hold	12,800	–	–	0.53%	35
2022 Q1	$761K	Hold	12,800	–	–	0.46%	36
2021 Q4	$929K	Hold	12,800	–	–	0.58%	30
2021 Q3	$894K	Hold	12,800	–	–	0.61%	31
2021 Q2	$881K	Hold	12,800	–	–	0.62%	35
2021 Q1	$827K	Buy	12,800 +3,200	+33%	+$206K	0.61%	36
2020 Q4	$559K	Buy	+9,600	New	+$579K	0.44%	39

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Scott Investment Partners's GILD Position: Q3 2023 in Review

Scott Investment Partners held its Gilead Sciences (GILD) position steady in Q3 2023 at 12,800 shares worth $959K. The position accounts for 2.2% of the portfolio, ranked #20.

Scott Investment Partners first reported a position in GILD in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.1M in Q4 2022. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Scott Investment Partners held 12,800 shares of Gilead Sciences worth $959K as of Q3 2023.
Scott Investment Partners left its Gilead Sciences share count unchanged in Q3 2023.
Gilead Sciences made up 2.2% of Scott Investment Partners's portfolio in Q3 2023, its #20 holding.
Scott Investment Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 12 quarters since.
Scott Investment Partners's Gilead Sciences position peaked at $1.1M in Q4 2022.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Scott Investment Partners's 13F filing for Q3 2023, filed 1 Nov 2023.